• Western blot analysis of lysate from COS7 cells, using OBCAM antibody.
  • Western blot analysis of various cells using OBCAM Polyclonal Antibody diluted at 1:1000

Anti-OPCML antibody (152-201) (STJ94590)

SKU:
STJ94590

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse/Rat/Monkey
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Opioid-binding protein/cell adhesion molecule (152-201) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
ELISA 1:10000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: OPCML
Gene ID: 4978
Uniprot ID: OPCM_HUMAN
Immunogen Region: 152-201
Specificity: OBCAM Polyclonal Antibody detects endogenous levels of OBCAM protein.
Immunogen: The antiserum was produced against synthesized peptide derived from human OBCAM. AA range:152-201
Function Binds opioids in the presence of acidic lipids.probably involved in cell contact.
Protein Name Opioid-Binding Protein/Cell Adhesion Molecule
Obcam
Opcml
Opioid-Binding Cell Adhesion Molecule
Iglon Family Member 1
Database Links Reactome: R-HSA-163125
Cellular Localisation Cell Membrane
Lipid-Anchor
Gpi-Anchor
Alternative Antibody Names Anti-Opioid-Binding Protein/Cell Adhesion Molecule antibody
Anti-Obcam antibody
Anti-Opcml antibody
Anti-Opioid-Binding Cell Adhesion Molecule antibody
Anti-Iglon Family Member 1 antibody
Anti-OPCML antibody
Anti-IGLON1 antibody
Anti-OBCAM antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance